|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.05 CNY | +1.42% |
|
+0.80% | -3.77% |
| Jun. 03 | Buchang Pharma Unit Completes Business Scope Expansion | MT |
| May. 26 | Buchang Pharma Subsidiary Adds Health Food to Business Scope | MT |
| Capitalization | 15.87B 2.34B 2.03B 1.86B 1.75B 3.26B 223B 3.31B 22.13B 8.61B 108B 8.8B 8.61B 375B | P/E ratio 2024 |
-30.9x | P/E ratio 2025 | 45.8x |
|---|---|---|---|---|---|
| Enterprise value | 18.38B 2.71B 2.35B 2.16B 2.03B 3.78B 259B 3.84B 25.63B 9.98B 125B 10.19B 9.97B 435B | EV / Sales 2024 |
1.76x | EV / Sales 2025 | 1.6x |
| Free-Float |
37.44% | Yield 2024 * |
-
| Yield 2025 | 3.64% |
| 1 day | +1.42% | ||
| 1 week | +0.80% | ||
| Current month | +0.80% | ||
| 1 month | -7.56% | ||
| 3 months | -7.56% | ||
| 6 months | -11.26% | ||
| Current year | -3.77% |
| 1 week | 14.8 |  | 15.37 |
| 1 month | 14.73 | | 16.93 |
| Current year | 14.73 | | 17.98 |
| 1 year | 14.73 | | 20.58 |
| 3 years | 13.83 | | 22.28 |
| 5 years | 13.83 | | 28.38 |
| 10 years | 13.83 | | 91.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chao Zhao
PSD | President | 59 | 2012-03-10 |
Xiao Gang Zhao
DFI | Director of Finance/CFO | 47 | 2025-01-16 |
Xi Fang Wang
CTO | Chief Tech/Sci/R&D Officer | 67 | 2017-03-25 |
| Director | Title | Age | Since |
|---|---|---|---|
Tao Zhao
CHM | Chairman | 60 | 2012-03-10 |
Chao Zhao
BRD | Director/Board Member | 59 | 2012-03-10 |
Bing Wu
BRD | Director/Board Member | 59 | 2001-05-09 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.42% | +0.80% | -8.90% | -32.12% | 2.34B | |
| +0.43% | -2.26% | -13.38% | -8.53% | 12.86B | |
| +0.72% | -2.42% | -33.18% | -57.28% | 5.07B | |
| +2.06% | -0.78% | -9.16% | -5.43% | 4.7B | |
| -1.09% | -3.73% | +15.26% | -25.50% | 3.92B | |
| +1.74% | +1.67% | +3.21% | -7.62% | 3.81B | |
| +1.52% | -5.06% | +6.13% | -46.10% | 3.8B | |
| +0.92% | +0.85% | -13.53% | -10.36% | 3.13B | |
| +1.78% | +1.78% | -9.45% | +26.88% | 1.81B | |
| +0.93% | -2.33% | -16.59% | -18.74% | 1.72B | |
| Average | +1.04% | -1.70% | -7.96% | -18.48% | 4.32B | |
| Weighted average by Cap. | +0.88% | -1.80% | -9.19% | -19.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.01B 1.62B 1.41B 1.29B 1.21B 2.26B 155B 2.3B 15.35B 5.97B 74.87B 6.1B 5.97B 260B | 11.88B 1.75B 1.52B 1.39B 1.31B 2.44B 167B 2.48B 16.56B 6.44B 80.79B 6.58B 6.44B 281B |
| Net income | -554M -81.75M -70.8M -64.96M -61.12M -114M -7.79B -116M -772M -301M -3.77B -307M -300M -13.1B | 361M 53.26M 46.12M 42.32M 39.82M 74.16M 5.08B 75.32M 503M 196M 2.45B 200M 196M 8.54B |
| Net Debt | 2.49B 368M 319M 292M 275M 512M 35.07B 521M 3.48B 1.35B 16.96B 1.38B 1.35B 58.99B | 2.51B 371M 321M 295M 277M 516M 35.34B 524M 3.5B 1.36B 17.09B 1.39B 1.36B 59.43B |
Employees
7,237
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-05 | 15.05 ¥ | +1.42% | 4,612,072 |
| 26-06-04 | 14.84 ¥ | -2.18% | 4,777,870 |
| 26-06-03 | 15.17 ¥ | -0.91% | 5,035,367 |
| 26-06-02 | 15.31 ¥ | +0.99% | 5,708,316 |
| 26-06-01 | 15.16 ¥ | +1.54% | 5,201,261 |
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603858 Stock
Select your edition
All financial news and data tailored to specific country editions
